Resveratrol treatment induces redox stress in red blood cells: A possible role of caspase 3 in metabolism and anion transport

Biological Chemistry

Volumn 391, Issue 9, 2010, Pages 1057-1065

  Galtieri, Antonio ^a   Tellone, Ester ^a   Ficarra, Silvana ^a   Russo, Annamaria ^a   Bellocco, Ersilia ^a   Barreca, Davide ^a   Scatena, Roberto ^b,c   Laganà, Giuseppina ^a   Leuzzi, Ugo ^a   Giardina, Bruno ^b,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c CNR   (Italy)

Author keywords

Band 3 protein; caspase 3; hemoglobin; metabolism; red blood cell; resveratrol

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; CASPASE 3; HEMOGLOBIN; OXYGEN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SUPEROXIDE;

ANION TRANSPORT; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE GHOST; ERYTHROCYTE MEMBRANE; HEMOLYSIS; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; OXYGEN AFFINITY; PRIORITY JOURNAL;

ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; CASPASE 3; ERYTHROCYTES; HUMANS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; STILBENES;

EID: 77957573766     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2010.100     Document Type: Article

References (61)

1. Aggarwal, B.B. and Shishodia, S. (2006). Resveratrol in health and diseases (Boca Raton, FL, USA: CRC Press).
2. Bhardwaj, A., Sethi, G., Vadhan-Raj, S., Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A.S., Shishodia, S., and Aggarwal, B.B. (2007). Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell sur-vival gene products in human multiple myeloma cells. Blood 109, 2293-2302.
3. Bhat, K.P., Lantvit, D., Christov, K., Mehta, R.G., Moon, R.C., and Pezzuto, J.M. (2001). Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 61, 7456-7463.
4. Blois, M.S. (1958). Antioxidant determinations by the use of a stable free radical. Nature 181, 1199-1200.
5. Chu, H. and Low, P.S. (2006). Mapping of glycolytic enzyme-bind-ing sites on human erythrocyte band 3. Biochem. J. 400, 143-151.
6. Csaki, C., Keshishzadeh, N., Fischer, K., and Shakibaei, M. (2008). Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem. Pharmacol. 75, 677-687.
7. Cui, Y., Xie, H., and Wang, J. (2005). Potential biochemical prop-erties of Pinus massoniana bark extract. Phytother. Res. 19, 34-38.
8. Dai, Z., Li, Y., Quarles, L.D., Song, T., Pan, W., Zhou, H., and Xiao, Z. (2007). Resveratrol enhances proliferation and osteo-blastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine 14, 806-814.
9. De la Lastra, C.A. and Villegas, I. (2005). Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol. Nutr. Food Res. 49, 405-430.
10. De Rosa, M.C., Alinovi, C.C., Galtieri, A., Russo, A., and Giardina, B. (2008). Allosteric properties of hemoglobin and the plasma membrane of the erythrocyte: new insights in gas transport and metabolic modulation. IUBMB Life 60, 87-93.
11. Delmas, D., Lancon, A., Colin, D., Jannin, B., and Latruffe, N. (2006). Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr. Drug Targets 7, 423-442.
12. Elmali, N., Baysal, O., Harma, A., Esenkaya, I., and Mizrak, B. (2007). Effects of resveratrol in inflammatory arthritis. Inflammation 30, 1-6.
13. Elmali, N., Esenkaya, I., Harma, A., Ertem, K., Turzok, Y., and Mizrak, B. (2005). Effect of resveratrol in experimental osteo-arthritis in rabbits. Inflamm. Res. 54, 158-162.
14. Ficarra, S., Tellone, E., Giardina, B., Scatena, R., Russo, A., Misiti, F., Clementi, M.E., Colucci, D., Bellocco, E., Laganà, G., et al. (2009). Derangement of erythrocytic AE1 in β-thalassaemia by caspase 3: pathogenic mechanisms and implications in red blood cells senescence. J. Membr. Biol. 228, 43-49.
15. Fuggetta, M.P., Lanzilli, G., Tricarico, M., Cottarelli, A., Falchetti, R., Ravagnan, G., and Bonmassar, E. Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro. (2006). J. Exp. Clin. Cancer Res. 25, 189-193.
16. Fulda, S. and Debatin, K.M. (2004). Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res. 64, 337-346.
17. Galtieri, A., Tellone, E., Romano, L., Misiti, F., Bellocco, E., Ficar-ra, S., Russo, A., Di Rosa, D., Castagnola, M., Giardina, B., et al. (2002). Band-3 protein function in human erythrocytes: effect of oxygenation-deoxygenation. Biochim. Biophys. Acta 1564, 214-218.
18. Giardina, B. and Amiconi, G. (1981). Measurement ofbinding of gaseous and nongaseous ligands to hemoglobin by conventional spectrophotometric procedures. Methods Enzymol. 76, 417-427.
19. Giardina, B., Messana, I., Scatena, R., and Castagnola, M. (1995). The multiple functions of hemoglobin. Crit. Rev. Biochem. Mol. Biol. 30, 165-196.
20. Gordon, J.L. (1986). Extracellular ATP: effects, sources, and fate. Biochem. J. 233, 309-319.
21. Harikumar, K.B. and Aggarwal, B.B. (2008). Resveratrol: a multi-targeted agent for age-associated chronic diseases. Cell Cycle 7, 1020-1035.
22. Howitz, K.T., Bitterman, KJ., Cohen, H.Y., Lamming, D.W., Lavu, S., Wood, J.G., Zipkin, R.E., Chung, P., Kisielewski, A., Zhang, L.L., et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196.
23. Hsu, C.Y. (2006). Antioxidant activity of extract from Polygonum aviculare. Biol. Res. 39, 281-288.
24. Jagger, J.E., Bateman, R.M., Ellsworth, M.L., and Ellis, C.G. (2001). Role oferythrocyte in regulating local O2 delivery medi-ated by hemoglobin oxygenation. Am. J. Physiol. Heart Circ. Physiol. 280, 2833-2839.
25. Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Bee-cher, C.W., Fong, H.H., Farnsworth, NR., Kinghorn, A.D., Meh-ta, R.G., et al. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220.
26. Kliman, HJ. and Steck, T.L. (1980). Association ofglyceraldehyde-3- phosphate dehydrogenase with the human red cell membrane. A kinetic analysis. J. Biol. Chem. 255, 6314-6321.
27. Laberge, M., Kovesi, I., Yonetani, T., and Fidy, J. (2005). R-state hemoglobin bound to heterotropic effectors: model of the DPG, IHP and RSR 13 binding sites. FEBS Lett. 579, 627-635.
28. Labotka, RJ. (1984). Measurement of intracellular pH and deoxy-hemoglobin concentration in deoxygenated erythrocytes by phosphorus-31 nuclear magnetic resonance. Biochemistry 23, 5549-5555.
29. Lancon, A., Delmas, D., Osman, H., Thenot, J.P., Jannin, B., and Latruffe, N. (2004). Human hepatic cell uptake of resveratrol: involvement ofboth passive diffusion and carrier-mediated proc-ess. Biochem. Biophys. Res. Commun. 316, 1132-1137.
30. Lanzilli, G., Fuggetta, M.P., Tricarico, M., Cottarelli, A., Serafino, A., Falchetti, R., Ravagnan, G., Turriziani, M., Adamo, R., Fran-cese, O., et al. (2006). Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro. Int. J. Oncol. 28, 641-648.
31. Le Corre, L., Chalabi, N., Delort, L., Mignon, YJ., and Bernard-Gallon, DJ. (2005). Resveratrol and breast cancer chemopre-vention: molecular mechanisms. Mol. Nutr. Food Res. 49, 462-471.
32. Low, P.S. (1986). Structure and function of the cytoplasmic domain of band 3: centre of erythrocyte membrane-peripheral protein interactions. Biochim. Biophys. Acta 864, 145-167.
33. Maccaglia, A., Mallozzi, C., and Minetti, M. (2003). Differential effects of quercetin and resveratrol on Band 3 tyrosine phospho-rylation signalling of red blood cells. Biochem. Biophys. Res. Commun. 305, 541-547.
34. Mandal, D., Moitra, P.K., Saha, S., and Basu, J. (2002). Caspase 3 regulates phosphatidylserine externalization and phagocitosis of oxidatively stressed erythrocytes. FEBS Lett. 513, 184-188.
35. Mandal, D., Baudin-Creuza, V, Bhattacharyya, A., Pathak, S., Delaunay, J., Kundu, M., and Basu, J. (2003). Caspase 3-medi-ated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchanger 1 (band 3). J. Biol. Chem. 278, 52551-52558.
36. Martin, A.R., Villegas, I., Sanchez-Hidalgo, M., and de la Lastra, C.A. (2006). The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experi-mentally induced colitis model. Br. J. Pharmacol. 147, 873-885.
37. Martinez, J. and Moreno, JJ. (2000). Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and pros-taglandin production. Biochem. Pharmacol. 59, 865-870.
38. Messana, I., Orlando, M., Cassiano, L., Pennacchietti, L., Zuppi, C., Castagnola, M., and Giardina, B. (1996). Human erythrocyte metabolism is modulated by the O2-linked transition of hemo-globin. FEBS Lett. 390, 25-28.
39. Misiti, F., Orsini, F., Clementi, M.E., Masala, D., Tellone, E., Gal-tieri, A., and Giardina, B. (2008). Amyloid peptide inhibits ATP release from human erythrocytes. Biochem. Cell Biol. 86, 501-508.
40. 2 terminus ofband 3. J. Biol. Chem. 256, 11203-11208.
41. Nishimiki, M., Appaji, N., and Yagi, K. (1972). The occurrence of superoxide anion in the reaction of reduced phenazine metho-sulphate and molecular oxygen. Biochem. Biophys. Res. Commun. 46, 849-854.
42. Perutz, M.F., Fermi, G., Abraham, DJ., Poyart, C., and Bursaux, E. (1986). Hemoglobin as a receptor of drugs and peptides: X-ray studies of the stereochemistry of binding. J. Am. Chem. Soc. 108, 1064-1078.
43. Pinto, M.C., Garcia-Barrado, J.A., and Macias, P. (1999). Resvera-trol is a potent inhibitor of the dioxygenase activity of lipoxy-genase. J. Agric. Food Chem. 47, 4842-4846.
44. Provinciali, M., Re, F., Donnini, A., Orlando, F., Bartozzi, B., Di Stasio, G., and Smorlesi, A. (2005). Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. Int. J. Cancer 115, 36-45. (Pubitemid 40559666)
45. Rahman, I., Biswas, S.K., and Kirkham, P.A. (2006). Regulation of inflammation and redox signalling by dietary polyphenols. Biochem. Pharmacol. 72, 1439-1452. (Pubitemid 44666744)
46. Romano, L., Peritore, D., Simone, E., Sidoti, A., Trischitta, F., and Romano, P. (1998). Chloride-sulphate exchange chemically measured in human erythrocyte ghosts. Cell Mol. Biol. 44, 351-355.
47. Russo, A., Tellone, E., Ficarra, S., Giardina, B., Bellocco, E., Laga-nà, G., Leuzzi, U., Kotyk, A., and Galtieri, A. (2008). Band 3 protein function in Teleost fish erythrocytes: effect of oxygen-ation- deoxygenation. Physiol. Res. 57, 49-54.
48. Shakibaei, M., John, T., Seifarth, C., and Mobasheri, A. (2007a). Resveratrol inhibits IL-1β-induced stimulation ofcaspase-3 and cleavage ofPARP in human articular chondrocytes in vitro. Ann. NY Acad. Sci. 1095, 554-563.
49. Shakibaei, M., John, T., Schulze-Tanzil, G., Lehmann, I., and Mobasheri, A. (2007b). Suppression of NF-κB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondro-cytes: implications for the treatment of osteoarthritis. Biochem. Pharmacol. 73, 1434-1445.
50. Shibayama, N., Miura, S., Tame, J.R.H., Yonetani, T., and Park, S.Y. (2002). Crystal structure of horse carbonmonoxyhemoglobin-bezafibrate complex at 1.55-A resolution. J. Biol. Chem. 277, 38791-38796.
51. Signorelli, P. and Ghidoni, R. (2005). Resveratrol in an anticancer nutrient: molecular basis, open questions and promises. J. Nutr. Biochem. 16, 449-466.
52. Sprague, R.S., Olearczyk, JJ., Spence, D.M., Stephenson, A.H., Sprung, R.W., and Lonigro, AJ. (2003). Extracellular ATP signalling in the rabbit lung: erythrocytes as determinants of vascular resistance. Am. J. Physiol. 285, 693-700.
53. Tang, L.L., Gao, J.S., Chen, X.R., and Xie, X. (2006). Inhibitory effect of resveratrol on the proliferation of synoviocytes in rheu-matoid arthritis and its mechanism in vitro. Zhong Nan Da Xue Xue Bao Yi Xue Ban 31, 528-533.
54. Tellone, E., Ficarra, S., Giardina, B., Scatena, R., Russo, A., Cle-menti, M.E., Misiti, F., Bellocco, E., and Galtieri, A. (2008a). Oxidative effect of gemfibrozil on anion influx and metabolism in normal and β-thalassaemic erythrocytes, physiological impli-cations. J. Membr. Biol. 224, 1-8.
55. Tellone, E., Ficarra, S., Scatena, R., Giardina, B., Kotyk, A., Russo, A., Colucci, D., Bellocco, E., Lagana', G., and Galtieri, A. (2008b). Influence of gemfibrozil on sulphate transport in human erythrocytes during the oxygenation-deoxygenation cycle. Physiol. Res. 57, 621-629.
56. Valenzano, D.R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., and Cellerino, A. (2006). Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived verte-brate. Curr. Biol. 16, 296-300.
57. Walder, J.A., Chatterjee, R., Steck, T.L., Low, P.S., Musso, G.F., Kaiser, E.T., Rogers, P.H., and Arnone, A. (1984). The inter-action of hemoglobin with the cytoplasmic domain of band 3 of the human erythrocyte membrane. J. Biol. Chem. 259, 10238-10246.
58. Wood, J.G., Rogina, B., Lavu, S., Howitz, K., Helfand, S.L., Tatar, M., and Sinclair, D. (2004). Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686-689.
59. Zhong, L., Yuying, Z., Hui, L., Jianglan, Y., Zhongliang, Z., and Guolin, Z. (2007). Transport of a cancer chemopreventive poly-phenol, resveratrol: interaction with serum albumin and hemo-globin. J. Fluoresc. 17, 580-587.
60. Zijlstra, W.G., Buursma, A., and Meeuwsen-Van Der Roest, W.P. (1991). Absorption spectra of human fetal and adult oxyhemo-globin, de-oxyhemoglobin, carboxyhemoglobin and methemo-globin. Clin. Chem. 37, 1633-1638.
61. Zipser, Y. and Kosover, N.S. (1996). Phosphotyrosine phosphatase associated with band 3 protein in human erythrocyte membrane. Biochem. J. 314, 881-887.